» Articles » PMID: 2207506

The Ontogeny of Purinoceptors in Rat Urinary Bladder and Duodenum

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1990 Aug 1
PMID 2207506
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

1. The ontogeny of responses to purines and analogues of smooth muscle preparations was studied in rat duodenum and rat urinary bladder. 2. Responses to adenosine and to adenosine 5'-triphosphate (ATP) mediated by P1- and P2-purinoceptors respectively were present as early as postnatal day 2, the earliest day studied. 3. In rat bladder, adenosine was inhibitory and ATP and adenosine 5'-(beta, gamma-methylene) triphosphonate (AMP-PCP) were excitatory, acting on the P2X subtype of P2-purinoceptors. Adenosine was more potent in the neonate than in the adult, while the potency of the nucleotides initially increased with age but then declined, being highest between postnatal days 10 and 25. 4. In rat duodenum also, adenosine was inhibitory, its potency being less than the adult before day 15. 5. ATP at low concentrations was inhibitory in rat duodenum at every age studied and its potency increased with age, but higher concentrations of ATP (3 microM and above) were excitatory until day 15. Both relaxations and contractions were mediated by the P2Y subtype of P2-purinoceptors. These ATP-induced contractions were not inhibited by indomethacin (25 microM) or by tetrodotoxin (1 microM) and are therefore not due to prostaglandin synthesis or to ATP-induced release of transmitter substances from nerves. 6. These results show that responses to adenosine and to adenine nucleotides are present from birth and vary with age, and that the changes seen indicate a differential development for P1-, P2X- and P2Y-purinoceptors.

Citing Articles

Purinergic signalling in the urinary tract in health and disease.

Burnstock G Purinergic Signal. 2013; 10(1):103-55.

PMID: 24265069 PMC: 3944045. DOI: 10.1007/s11302-013-9395-y.


P2X2 and P2X3 receptor expression in postnatal and adult rat urinary bladder and lumbosacral spinal cord.

Studeny S, Torabi A, Vizzard M Am J Physiol Regul Integr Comp Physiol. 2005; 289(4):R1155-68.

PMID: 15947072 PMC: 1305916. DOI: 10.1152/ajpregu.00234.2005.


Age-dependent changes in particulate and soluble guanylyl cyclase activities in urinary tract smooth muscle.

Wheeler M, Pontari M, Dokita S, Nishimoto T, Cho Y, Hong K Mol Cell Biochem. 1997; 169(1-2):115-24.

PMID: 9089638 DOI: 10.1023/a:1006823611864.


Differential development of adenosine A1 and A2b receptors in the rat duodenum.

Peachey J, Hourani S, Kitchen I Br J Pharmacol. 1996; 119(5):949-58.

PMID: 8922745 PMC: 1915942. DOI: 10.1111/j.1476-5381.1996.tb15764.x.


The ontogenetic profiles of the pre- and postjunctional adenosine receptors in the rat vas deferens.

Peachey J, Brownhill V, Hourani S, Kitchen I Br J Pharmacol. 1996; 117(6):1105-10.

PMID: 8882603 PMC: 1909757. DOI: 10.1111/j.1476-5381.1996.tb16703.x.


References
1.
Burnstock G, Dumsday B, Smythe A . Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol. 1972; 44(3):451-61. PMC: 1665813. DOI: 10.1111/j.1476-5381.1972.tb07283.x. View

2.
Burnstock G, Campbell G, Satchell D, Smythe A . Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol. 1970; 40(4):668-88. PMC: 1702901. DOI: 10.1111/j.1476-5381.1970.tb10646.x. View

3.
Burnstock G, Satchell D, Smythe A . A comparison of the excitatory and inhibitory effects of non-adrenergic, non-cholinergic nerve stimulation and exogenously applied ATP on a variety of smooth muscle preparations from different vertebrate species. Br J Pharmacol. 1972; 46(2):234-42. PMC: 1666337. DOI: 10.1111/j.1476-5381.1972.tb06868.x. View

4.
Gershon M, Thompson E . The maturation of neuromuscular function in a multiply innervated structure: development of the longitudinal smooth muscle of the foetal mammalian gut and its cholinergic excitatory, adrenergic inhibitory, and non-adrenergic inhibitory innervation. J Physiol. 1973; 234(2):257-77. PMC: 1350628. DOI: 10.1113/jphysiol.1973.sp010345. View

5.
Burnstock G, Cocks T, Paddle B, STASZEWSKA-BARCZAK J . Evidence that prostaglandin is responsible for the 'rebound contraction' following stimulation of non-adrenergic, non-cholinergic ('purinergic') inhibitory nerves. Eur J Pharmacol. 1975; 31(2):360-2. DOI: 10.1016/0014-2999(75)90060-6. View